403 related articles for article (PubMed ID: 17994573)
1. Benzene-1,2-, 1,3-, and 1,4-di-N-substituted carbamates as conformationally constrained inhibitors of acetylcholinesterase.
Lin MC; Hwang MT; Chang HG; Lin CS; Lin G
J Biochem Mol Toxicol; 2007; 21(6):348-53. PubMed ID: 17994573
[TBL] [Abstract][Full Text] [Related]
2. Comparison of active sites of butyrylcholinesterase and acetylcholinesterase based on inhibition by geometric isomers of benzene-di-N-substituted carbamates.
Chiou SY; Huang CF; Hwang MT; Lin G
J Biochem Mol Toxicol; 2009; 23(5):303-8. PubMed ID: 19827033
[TBL] [Abstract][Full Text] [Related]
3. Benzene-di-N-substituted carbamates as conformationally constrained substrate analogs of cholesterol esterase.
Chiou SY; Lin MC; Hwang MT; Chang HG; Lin G
Protein J; 2008 Aug; 27(5):276-82. PubMed ID: 18478319
[TBL] [Abstract][Full Text] [Related]
4. Substrate activation of butyrylcholinesterase and substrate inhibition of acetylcholinesterase by 3,3-dimethylbutyl-N-n-butylcarbamate and 2-trimethylsilyl-ethyl-N-n-butylcarbamate.
Chiou SY; Wu YG; Lin YF; Lin LY; Lin G
J Biochem Mol Toxicol; 2007; 21(1):24-31. PubMed ID: 17366539
[TBL] [Abstract][Full Text] [Related]
5. Ortho effects for inhibition mechanisms of butyrylcholinesterase by o-substituted phenyl N-butyl carbamates and comparison with acetylcholinesterase, cholesterol esterase, and lipase.
Lin G; Lee YR; Liu YC; Wu YG
Chem Res Toxicol; 2005 Jul; 18(7):1124-31. PubMed ID: 16022504
[TBL] [Abstract][Full Text] [Related]
6. A rate determining step change in the pre-steady state of acetylcholinesterase inhibitions by 1,n-alkane-di-N-butylcarbamates.
Lin G; Tseng HC; Chio AC; Tseng TM; Tsai BY
Bioorg Med Chem Lett; 2005 Feb; 15(4):951-5. PubMed ID: 15686892
[TBL] [Abstract][Full Text] [Related]
7. Novel Benzene-Based Carbamates for AChE/BChE Inhibition: Synthesis and Ligand/Structure-Oriented SAR Study.
Bak A; Kozik V; Kozakiewicz D; Gajcy K; Strub DJ; Swietlicka A; Stepankova S; Imramovsky A; Polanski J; Smolinski A; Jampilek J
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934674
[TBL] [Abstract][Full Text] [Related]
8. Ortho effects in quantitative structure-activity relationships for acetylcholinesterase inhibition by aryl carbamates.
Lin G; Liu YC; Lin YF; Wu YG
J Enzyme Inhib Med Chem; 2004 Oct; 19(5):395-401. PubMed ID: 15648653
[TBL] [Abstract][Full Text] [Related]
9. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors.
Więckowska A; Bajda M; Guzior N; Malawska B
Eur J Med Chem; 2010 Dec; 45(12):5602-11. PubMed ID: 20926161
[TBL] [Abstract][Full Text] [Related]
10. Molecular recognition by acetylcholinesterase at the peripheral anionic site: structure-activity relationships for inhibitions by aryl carbamates.
Lin G; Lai CY; Liao WC
Bioorg Med Chem; 1999 Dec; 7(12):2683-9. PubMed ID: 10658572
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.
Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Kunimoto R; Tsumura Y; Akaike A; Niidome T; Okuno Y; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1718-20. PubMed ID: 20137934
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors.
Horáková E; Drabina P; Brož B; Štěpánková Š; Vorčáková K; Královec K; Havelek R; Sedlák M
J Enzyme Inhib Med Chem; 2016; 31(sup3):173-179. PubMed ID: 27476673
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of a new series of tri-, di-, and mono-N-alkylcarbamylphloroglucinols as bulky inhibitors of acetylcholinesterase.
Lin MC; Lin GZ; Shen YF; Jian SY; Hsieh DK; Lin J; Lin G
Chem Res Toxicol; 2012 Jul; 25(7):1462-71. PubMed ID: 22690874
[TBL] [Abstract][Full Text] [Related]
14. Quantitative structure-activity relationships for the pre-steady state acetylcholinesterase inhibition by carbamates.
Lin G; Liao WC; Chan CH; Wu YH; Tsai HJ; Hsieh CW
J Biochem Mol Toxicol; 2004; 18(6):353-60. PubMed ID: 15674842
[TBL] [Abstract][Full Text] [Related]
15. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking.
Imramovsky A; Stepankova S; Vanco J; Pauk K; Monreal-Ferriz J; Vinsova J; Jampilek J
Molecules; 2012 Aug; 17(9):10142-58. PubMed ID: 22922284
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of enantiomers of exo-2-norbornyl-N-n-butylcarbamate and endo-2-norbornyl-N-n-butylcarbamate for stereoselective inhibition of acetylcholinesterase.
Chiou SY; Huang CF; Yeh SJ; Chen IR; Lin G
Chirality; 2010 Feb; 22(2):267-74. PubMed ID: 19496158
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.
Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Tsumura Y; Akaike A; Niidome T; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1721-3. PubMed ID: 20137941
[TBL] [Abstract][Full Text] [Related]
19. 4-Aminopyridine derivatives with anticholinesterase and antiamnesic activity.
Scipione L; De Vita D; Musella A; Flammini L; Bertoni S; Barocelli E
Bioorg Med Chem Lett; 2008 Jan; 18(1):309-12. PubMed ID: 18023348
[TBL] [Abstract][Full Text] [Related]
20. Benzene-di-N-octylcarbamates as conformationally constrained phospholipase A(2) inhibitors.
Lin G; Lin YF; Hwang MT; Lin YZ
Bioorg Med Chem Lett; 2004 Feb; 14(3):751-5. PubMed ID: 14741283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
